Obermatt
See Similar Stocks →

Sinovac Biotech

NSQ:SVA · AGP8696W1045
BiotechnologyMedium

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book—
Dividend Yield1
Revenue Growth39
Profit Growth54
Capital Growth6
TSR 52w—
Leverage80
Liquidity8
Refinancing100
Combined—
Analyst Opinions—
Pro Holdings20
Opinion Changes—
Market Pulse1

Profile

CountryChina
IndustryBiotechnology
SizeMedium
TypePrivate Company
ExchangeNASDAQGS
Founded1999
Employees111
Websitesinovac.com
ISINAGP8696W1045
Last UpdateApr 2, 2026
Index & Theme
ImmunologyVaccinesInfectious DiseasesBiotechnologyPharmaceuticalTherapeutics

Description

Sinovac Biotech Ltd. operates as a biopharmaceutical company. The company focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including without limitation, hepatitis A…

Similar Stocks

The companies this stock is ranked against.

Compare Sinovac Biotech with its peers
PharmaEssentia
TAI:6446
62
CountryTaiwan
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Zai Lab
HKG:9688
32
CountryChina
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Green Cross
KSC:005250
28
CountrySouth Korea
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Shionogi
TYO:4507
70
CountryJapan
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
Wave Life Sciences
NMQ:WVE
20
CountrySingapore
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Sonic
ASX:SHL
36
CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →